药学实践杂志
藥學實踐雜誌
약학실천잡지
THE JOURNAL OF PHARMACEUTICAL PRACTICE
2014年
3期
222-224
,共3页
李基明%张慧芬%谢辉%沈彤
李基明%張慧芬%謝輝%瀋彤
리기명%장혜분%사휘%침동
婴幼儿肺炎%抗生素相关腹泻%布拉酵母菌
嬰幼兒肺炎%抗生素相關腹瀉%佈拉酵母菌
영유인폐염%항생소상관복사%포랍효모균
infant pneumonia%antibiotic associated diarrhea%Saccharomyces boulardii
目的:探讨布拉酵母菌对婴幼儿肺炎继发抗生素相关腹泻( AAD)的防治作用。方法选择1个月至3岁婴幼儿肺炎住院患者302例,均静脉应用抗菌药物且连续治疗>5 d,排除慢性胃肠道疾病,随机分为对照组( A组,60例)、布拉酵母菌治疗组( B组,92例)和布拉酵母菌预防组( C组,150例)。入选患儿在抗感染治疗的同时, C组加用布拉酵母菌,B组继发腹泻后加用布拉酵母菌,观察各组患儿AAD的发生情况,比较分析各组疗效。结果 C组患儿AAD发生率明显低于A、B组患儿;各组患儿继发腹泻严重程度差异无统计学意义(P>0.05);腹泻持续时间差异有统计学意义(P<0.001),其中布拉酵母菌预防组腹泻持续时间最短,治疗组次之,对照组最长;抗腹泻总有效率差异有统计学意义(P<0.05),A组抗腹泻总有效率不如C组,尚不能认为A组与B组、B组与C组间抗腹泻疗效有差别。结论婴幼儿肺炎继发AAD后,应用布拉酵母菌,可缩短腹泻病程;若预防性应用布拉酵母菌不仅能降低AAD的发病率,还能缩短腹泻病程,提高AAD治疗疗效,值得在临床工作中推广预防应用。
目的:探討佈拉酵母菌對嬰幼兒肺炎繼髮抗生素相關腹瀉( AAD)的防治作用。方法選擇1箇月至3歲嬰幼兒肺炎住院患者302例,均靜脈應用抗菌藥物且連續治療>5 d,排除慢性胃腸道疾病,隨機分為對照組( A組,60例)、佈拉酵母菌治療組( B組,92例)和佈拉酵母菌預防組( C組,150例)。入選患兒在抗感染治療的同時, C組加用佈拉酵母菌,B組繼髮腹瀉後加用佈拉酵母菌,觀察各組患兒AAD的髮生情況,比較分析各組療效。結果 C組患兒AAD髮生率明顯低于A、B組患兒;各組患兒繼髮腹瀉嚴重程度差異無統計學意義(P>0.05);腹瀉持續時間差異有統計學意義(P<0.001),其中佈拉酵母菌預防組腹瀉持續時間最短,治療組次之,對照組最長;抗腹瀉總有效率差異有統計學意義(P<0.05),A組抗腹瀉總有效率不如C組,尚不能認為A組與B組、B組與C組間抗腹瀉療效有差彆。結論嬰幼兒肺炎繼髮AAD後,應用佈拉酵母菌,可縮短腹瀉病程;若預防性應用佈拉酵母菌不僅能降低AAD的髮病率,還能縮短腹瀉病程,提高AAD治療療效,值得在臨床工作中推廣預防應用。
목적:탐토포랍효모균대영유인폐염계발항생소상관복사( AAD)적방치작용。방법선택1개월지3세영유인폐염주원환자302례,균정맥응용항균약물차련속치료>5 d,배제만성위장도질병,수궤분위대조조( A조,60례)、포랍효모균치료조( B조,92례)화포랍효모균예방조( C조,150례)。입선환인재항감염치료적동시, C조가용포랍효모균,B조계발복사후가용포랍효모균,관찰각조환인AAD적발생정황,비교분석각조료효。결과 C조환인AAD발생솔명현저우A、B조환인;각조환인계발복사엄중정도차이무통계학의의(P>0.05);복사지속시간차이유통계학의의(P<0.001),기중포랍효모균예방조복사지속시간최단,치료조차지,대조조최장;항복사총유효솔차이유통계학의의(P<0.05),A조항복사총유효솔불여C조,상불능인위A조여B조、B조여C조간항복사료효유차별。결론영유인폐염계발AAD후,응용포랍효모균,가축단복사병정;약예방성응용포랍효모균불부능강저AAD적발병솔,환능축단복사병정,제고AAD치료료효,치득재림상공작중추엄예방응용。
Objective To investigate the therapeutic effect of Saccharomyces boulardii on antibiotics associated diarrhea (AAD)in infant pneumonia.Methods 302 hospitalized infant patients (1 month-3 years) with pneumonia but without gastroenteric disease were selected , and antibiotics were administrated intravenously at least 5 continuous days for each patient .Patients were all giv-en antibiotics and randomly divided into three groups:control group with no Saccharomyces boulardii administration ( group A, 60 ca-ses);Saccharomyces boulardii were applied as addition on the occurrence of diarrhea (group B, 92 cases), and Saccharomyces boular-dii and antibiotics were co-administrated (group C, 150 cases).Incidences of AAD in all groups were carefully examined and differ-ences of therapeutic effect between groups were compared and analyzed .Results The incidence of AAD in Group C was significantly lower than that in other groups .In term of diarrhea severity, no significant difference was observed in all groups (P>0.05).Howev-er, duration of diarrhea showed significant different between groups (P<0.001):group A with the longest duration and group C with the shortest .The results indicated that the total efficiency of anti-diarrhea in group C was significantly higher than that in control group (P<0.05).However, group B presented no significant difference compared with neither control group nor group C in term of therapeu -tic effect on diarrhea .Conclusion Administration of Saccharomyces boulardii Sachets could shorten the duration of diarrhea on the oc-currence of AAD in infant pneumonia .According to our results , Saccharomyces boulardii was effective in both preventing the develop-ment of AAD and shortening duration of diarrhea , and therefore improved therapeutic effect on ADD .